Moran James P 5
5 · IGC Pharma, Inc. · Filed May 15, 2025
Insider Transaction Report
Form 5
Moran James P
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-31+33,333→ 975,735 total - Exercise/Conversion
Common Stock
2025-03-31+80,000→ 1,055,735 total - Exercise/Conversion
Restricted Stock Units
2025-03-31−33,333→ 0 total→ Common Stock (33,333 underlying) - Exercise/Conversion
Common Stock
2025-03-31+50,000→ 1,105,735 total - Exercise/Conversion
Restricted Stock Units
2025-03-31−80,000→ 80,000 total→ Common Stock (80,000 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-31−50,000→ 100,000 total→ Common Stock (50,000 underlying)
Footnotes (4)
- [F1]On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023.
- [F2]On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.
- [F3]On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.
- [F4]Each restricted stock unit represents a right to receive one share of IGC common stock.